Award tenders
Awarded contractOpenSuppliesPoland

Dostawa substancji czynnej mirvetuximabum soravtansinum stosowanej w programie lekowym B.50 leczenia chorych na raka jajnika

1 supplier awarded•1 lot awarded•€1.45M awarded

Buyer: UNIWERSYTECKI SZPITAL KLINICZNY NR 2 PUM W SZCZECINIE / Szczecin, Poland

Published Jul 12, 2026Awarded Jul 09, 2026
Antineoplastic agents

Awarded value

€1.45M

Estimated value

€1.49M

Awarded at 97% of estimated value

Award date

Jul 09, 2026

Winners

1

Lots awarded

1

Winners

Abbvie Sp. z o.o

WARSZAWA, POL

1 lot

€1.4M This contract

1 award notice•1 awarded lot•€1.45M total

Lots awarded

LotTitleWinnerAward valueMain CPV
LOT-0001
Abbvie Sp. z o.o€1.4M

Antineoplastic agents (33652100)